Blood Preparation Market, By Antithrombotic and Anticoagulants Type (2021-2033)
- Platelet Aggregation Inhibitors
- Glycoprotein Inhibitors
- ADP Antagonists
- COX Inhibitors
- Others
- Fibrinolytics
- Streptokinase
- Tissue Plasminogen Activator (tPA)
- Urokinase
- Anticoagulants
- Heparins
- Low Molecular Weight Heparin (LMWH)
- Unfractionated Heparin
- Ultra-low Molecular Weight Heparin
- Direct Thrombin Inhibitors
- Vitamin K Antagonists
- Direct Factor Xa Inhibitors